Mohammed Aboukaoud

Tel aviv University, Sackler School of Medicine, Tel aviv, Israel

Publications
  • Research Article   
    Safety Comparison of Atomextine and Lisdexamfetamine: Using Pharmacovigilance Database and Tools
    Author(s): Mohammed Aboukaoud*

    Background Our study is the first to utilize the OpenVigil 2.1, a universal novel web-based pharmacovigilance analysis tool to analyze real-life safety of ADHD medications with special emphasis on newer medications and psychiatric adverse events. Thorough knowledge of adverse events for each medication reveals safety signals and support treatment guidelines and clinical management of the events. Methods we analyzed adverse event cases documented in the OpenVigil 2.1 from mid-2003 until February 2020. The medical dictionary for regulatory activities (MedDRA browser English version 20.0) was used to group lower level terms with a common preferred term to be searched for in the database. The proportional reporting ratio (PRR) and the reporting odd ratio (ROR) were used to quantitate the strength of the association between reported adverse events for atomoxetine, lisdexamfetamine, ampheta.. View more»

    DOI: 10.35248/2329-6887.21.9.315

    Abstract HTML PDF